Last updated: January 23, 2025
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fibromyalgia
Treatment
Low frequency TENS
Clinical Study ID
NCT06799091
Effect of neuromodulation
Ages 20-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
women between 20-45 years old, (ii) diagnoses according to the 2016 American College of Rheumatology criteria for fibromyalgia [1]
- Symptoms have been present at a similar level for at least three months (iii)Absence of other disorders that causes similar symptoms: systemic lupuserethromatosis (SLE), rheumatoid arthritis (RA) and Lyme disease based on laboratoryinvestigations (erythrocyte sedimentation rate (ESR), Anti anti-cyclic citrullinatedpeptide (Anti CCP), antinuclear antibody (ANA) and Rheumatoid factor (RF)).
Exclusion
Exclusion Criteria:
- any medical, neurological, or psychiatric illness, use of strong opioids or otherpainkillers except paracetamol and/or ibuprofen, benzodiazepine, illicit drug oralcohol use, recent use of cannabis, pregnancy, breast feeding, and the presence ofpain syndromes other than FM.
Presence of other autoimmune disorders e.g.: rheumatoid arthritis and systemic lupus erethromatosus
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Low frequency TENS
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
March 15, 2025
Study Description
Connect with a study center
Faculty of physical therapy laps at cairo university
Giza, 12612
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.